https://www.tctmd.com/news/reductions-plaque-inflammation-appear-explain-statin-benefit-hiv
A REPRIEVE trial substudy shows 2 years of pitavastatin lessened noncalcified plaque volume and risk of plaque progression.
Create an account or login to join the discussion